Hantavirus, the WHO, and the Conflicts in Weighing Mortality

In this Brownstone Institute article, David Bell argues that the recent hantavirus scare is being inflated by global health institutions while far deadlier, more persistent health crises are ignored.

• Bell contrasts the intense media and WHO attention on a small hantavirus outbreak with the daily global toll from malaria and tuberculosis.
• The article notes that three tourists died after a hantavirus outbreak aboard the MV Hondius, while fewer than 10 people were reportedly infected.
• Bell argues that the WHO’s response looks disproportionate when compared to the organization’s traditional focus on diseases of poverty.
• He says hantavirus is serious but rare, with transmission typically linked to rodents and limited human-to-human spread in most cases.
• The piece frames the episode as part of a broader push by the WHO to regain authority, funding, and political relevance after the Covid era.
• Bell criticizes the WHO’s pandemic agenda, arguing that it could divert billions of dollars away from malaria, TB, HIV, nutrition, and primary care.
• The article raises concerns about conflicts of interest, especially the influence of the Gates Foundation, Gavi, pharmaceutical companies, and vaccine-centered global health funding.
• Bell points to Moderna’s work on a hantavirus mRNA vaccine as an example of how public fear can help create markets for products tied to obscure diseases.
• The broader argument is that public health messaging has become distorted by institutional incentives, private interests, and a failure to weigh risks honestly.
• Bell concludes that citizens and public health professionals should demand institutions like the WHO act proportionately and ethically—or be replaced.

Read the full story: https://brownstone.org/articles/hantavirus-the-who-and-the-conflicts-in-weighing-mortality/